Ruanxin Biotechnology
Founded 2021
About Ruanxin Biotechnology
Ruanxin Biotechnology focuses on the research and development of injectable cartilage technology.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2026)
- Website: https://www.cartilageeng.com/s
Canonical: https://fsome.com/organization/ruanxin-biotechnology-12413701 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.